SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury
Safety Issues
About this trial
This is an interventional treatment trial for Safety Issues
Eligibility Criteria
Inclusion Criteria: Male or female adults, 18-60 years of age, with a clinical diagnosis of chronic traumatic SCI (≥ 3 months after SCI) Neurological examination: ASIA-A Both the spinal and neurological levels of injury were between T1-T12 Subjects must be able to read, write and complete visual analogue scale Voluntarily signs and dates an informed Consent form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures. Exclusion Criteria: Subjects with osteoporosis or had joint disease Severe head injury Severe pressure sore Sign of kidney, cardiovascular, liver disorders Subjects with internal medical and/or infectious diseases (including but not limited to Hepatitis B and HIV carriers) Pregnant women or women at lactation stages Medically or mentally unstable according to the judgment of the investigator History of multiple sclerosis or peripheral demyelination Any criteria which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol
Sites / Locations
- Kunming Tongren HospitalRecruiting